FIELD: medicine.
SUBSTANCE: invention refers to new compounds of formula: I where R1 represents hydrogen or C1-7-alkyl; R2 and R3 independently represent hydrogen; R4 and R5 independently represent hydrogen; R6, R7, R8 and R9 independently represent hydrogen, C1-7-alkyl; and one of R6, R7 and R8 represents where R10 represents hydrogen, C1-7-alkyl; R11 represents hydrogen, C1-7-alkyl; one of R12 or R13 represents hydrogen, C1-7-alkyl or fluorine-C1-7-alkyl; and the other represents undivided electron pair; R14 represents hydrogen, C1-7-alkyl, halogen; R15 represents aryl or aryl substituted with 1-3 groups chosen from C1-7-alkyl C1-7-alkoxy, halogen, fluorine-C1-7-alkyl and fluorine-C1-7-alkoxy; and n has a value 1, 2 or 3; and to all their enantiomers and to pharmaceutically acceptable salts and/or esters. The invention also concerns the pharmaceutical compositions.
EFFECT: production of new biologically active compounds with agonist activity with respect to PPARδ and PPARα.
20 cl, 25 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
HETEROARYL DERIVATIVES AS ACTIVATORS OF PEROXISOME PROLIFERATOR RECEPTORS (PPAR) | 2004 |
|
RU2367659C2 |
PYRAZOLE- AND PHENYL DERIVATIVES AS PPAR INHIBITORS | 2005 |
|
RU2384573C2 |
THIAZOLE-SUBSTITUTED INDOLYL-DERIVATIVES AND APPLICATION THEIROF AS PPAR MODULATORS | 2004 |
|
RU2344135C2 |
PHENYL DERIVATIVES CONTAINING ACETYLENE GROUP | 2005 |
|
RU2384565C2 |
PHENYL DERIVATIVES AS PPAR AGONISTS | 2004 |
|
RU2374230C2 |
BENZANNEALED COMPOUNDS AS PPAR ACTIVATORS | 2004 |
|
RU2367654C2 |
INDOLE DERIVATIVES CONTAINING ACETYLENE GROUP AS PPAR ACTIVATORS | 2005 |
|
RU2387639C2 |
3-PYRIDINE CARBOXAMIDE AND 2-PYRAZINE CARBOXAMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS | 2007 |
|
RU2454405C2 |
METHOD OF RESIDUAL LIPOPROTEINS PRODUCING INHIBITION | 2004 |
|
RU2330682C2 |
PYRIDINE-3-CARBOXAMIDE DERIVATIVES AS CB1 INVERSE AGONISTS | 2006 |
|
RU2404164C2 |
Authors
Dates
2009-12-10—Published
2005-02-28—Filed